Lara Diem

[Lara Diem @Lara_Diem]

Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study https://t.co/XMC8Q2dLam #LongCovid #fatigue #postcovid @LongCovidItalia @hellyhammer @HoepnerRobert @inselgruppe @BAG_OFSP_UFSP

[Lara Diem @Lara_Diem]

Possible association between hypogammaglobuliemia and MS-fatigue? #MultipleSclerosis #fatigue @inselgruppe

[Robert Hoepner @hoepner_robert]

#MultipleSclerosis and #fatigue please see our latest publication
Hypogammaglobulinemia: A contributing factor to Multiple Sclerosis Fatigue? https://t.co/7dlQMHeNU6
@MS_HealthUnion @shhhhletmevent @FatigueScience

[Robert Hoepner @hoepner_robert]

#MultipleSclerosis and #fatigue please see our latest publication
Hypogammaglobulinemia: A contributing factor to Multiple Sclerosis Fatigue? https://t.co/7dlQMHeNU6
@MS_HealthUnion @shhhhletmevent @FatigueScience

[Helly Hammer @hellyhammer]

@HoepnerRobert @hellyhammer #pandemic #vaccination #SafetyFirst #research Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients https://t.co/89aEpWQRjq #mdpivaccines via @MDPIOpenAccess

[Lara Diem @Lara_Diem]

Post-COVID-19 Study

"Fatigue (90.5%) was the most prevalent Post-COVID-19 symptom followed by depressive mood (52.4%) and sleep disturbance (47.6%)."
https://t.co/kAoGx8atex

#postcovid #LongCovid @inselgruppe @hellyhammer @HoepnerRobert @EANeurology @BAG_OFSP_UFSP

[Lara Diem @Lara_Diem]

Interessantes Symposium über Long COVID-19. #LongCovid #postcovid @inselgruppe @SGAIM_SSMIG @doctorfmh
https://t.co/KBOPKFRFqK

[Lara Diem @Lara_Diem]

Long COVID-19 Vortrag #LongCovid #postcovid @inselgruppe @pharmakey1

[pharmakey @pharmakey1]

https://t.co/YzELJzgWF0 geht mit dem Refresher-Symposium in die nächste Runde: Neue Formel, neuer Durchführungsort, bewährte Qualität! Profitieren Sie sofort vom Frühbucherangebot. Unser Geschenk: spannender online Vortrag "Post-COVID-Syndrom: die Langzeitfolgen" mit @Lara_Diem

[pharmakey @pharmakey1]

Post-Covid-Syndrom - die Langzeitfolgen der SARS-CoV-2 Pandemie! ... was sind die Red Flags? Welche Therapie-Möglichkeiten kennen wir bereits? Diese und weitere Fragen beantwortet unsere Referentin @Lara_Diem in unserer Post-COVID-Serie auf https://t.co/48DolyeRO8

[David Hess @hess_da]

Was löst #LongCovid aus?
➡️eine fixe Erklärung gibt es noch nicht
➡️Mediziner verfolgen wichtige Spur

Dr. med. @Lara_Diem vom Inselspital Bern erklärt in unserem @NZZ -Erklärvideo den neusten Stand der Forschung.

@NZZVideo @ConradinZ @inselgruppe
https://t.co/XXl4jyJ4PM

[Lara Diem @Lara_Diem]

#research #Postcovidsyndrome #PostCovid @inselgruppe

[Lara Diem @Lara_Diem]

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology,
Comorbidities and Association With Initial Course of ... https://t.co/Q72nhtyE93

[Lara Diem @Lara_Diem]

#Postcovidsyndrome #PostCovid #longcovid

[Lara Diem @Lara_Diem]

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology,
Comorbidities and Association With Initial Course of ... https://t.co/Q72nhtyE93

[Lara Diem @Lara_Diem]

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology,
Comorbidities and Association With Initial Course of ... https://t.co/Q72nhtyE93

[Lara Diem @Lara_Diem]

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology,
Comorbidities and Association With Initial Course of ... https://t.co/Q72nhtyE93

[Brain Sciences MDPI @BrainSci_MDPI]

#mdpibrainsci New Special Issue Open for Submission! Immunomodulation and Immunotherapy in Neurological Disorders edited by Dr. Maria Eleptheria Evangelopoulos and Dr. Lara Diem
https://t.co/kLEeIjyCyO
@MDPIOpenAccess
@Scilit_MDPI
#Neurology #neuroscience #brain #demyelination

[Lara Diem @Lara_Diem]

Vaccine Hesitancy in Patients With Multiple Sclerosis https://t.co/yixv0T1HPc. #vaccination #COVID19

[Lara Diem @Lara_Diem]

@rogerfederer Es gibt wichtigeres im Moment! Gesundheit!

[Lara Diem @Lara_Diem]

@repubblicait

[Lara Diem @Lara_Diem]

@rep_ambiente

[Lara Diem @Lara_Diem]

La neve si scioglie...